Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_89ac64d62baaa791ac712c93832985fd http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_afc5ceb1208e973ca55faebf80af09f1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_05a5364a0c557fcc87e24261395a3f3f |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-10 |
filingDate |
2010-03-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e576ebcbc2775e662c6f2a498a0dcd3b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ce80021e755f3d4bcdfc59d1f701b467 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a53243974ed6b09abc5d88fe27b7a7f3 |
publicationDate |
2020-01-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
BR-PI1000870-B1 |
titleOfInvention |
vaccine pharmaceutical formulations and their uses |
abstract |
vaccine pharmaceutical formulations and their uses. the present invention is for vaccine pharmaceutical formulations containing recombinant plasmid vectors constructed from the DNA sequence of the peptide p1o and / or combined with other vectors. further, the present application deals with the use of these recombinant vectors in the preparation of pharmaceutical formulations applied in infectious diseases, particularly paracoccidioidomycosis (pcm). |
priorityDate |
2010-03-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |